These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8237827)

  • 1. Antiarrhythmic versus antifibrillatory actions: inference from experimental studies.
    Lucchesi BR; Chi L; Friedrichs GS; Black SC; Uprichard AC
    Am J Cardiol; 1993 Nov; 72(16):25F-44F. PubMed ID: 8237827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessment of antiarrhythmic drugs.
    Lucchesi BR; Lynch JJ
    Fed Proc; 1986 Jul; 45(8):2197-205. PubMed ID: 3720962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrates and potential therapeutics of ventricular arrhythmias in heart failure.
    Zhang D; Tu H; Wadman MC; Li YL
    Eur J Pharmacol; 2018 Aug; 833():349-356. PubMed ID: 29940156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hopes and disappointments with antiarrhythmic drugs.
    Camm AJ
    Int J Cardiol; 2017 Jun; 237():71-74. PubMed ID: 28365182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.
    Weeks PA; Sieg A; Gass JA; Rajapreyar I
    Heart Fail Rev; 2016 Jul; 21(4):415-31. PubMed ID: 27003591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
    Friedrichs GS; Chi L; Gralinski MR; Black SC; Basler GC; Mu DX; Pewitt SR; Johnson CR; Lucchesi BR
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):314-23. PubMed ID: 7752658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect?
    Beri A; Contractor T; Khasnis A; Thakur R
    Am J Cardiovasc Drugs; 2010; 10(3):155-64. PubMed ID: 20524717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
    Seipel L; Kühlkamp V
    Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
    Doherty JU; Fuchs S; Tecce MA
    Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
    Abdel-Kawy HS
    Cardiovasc Ther; 2015 Apr; 33(2):27-34. PubMed ID: 25677801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.